<SEC-DOCUMENT>0001710496-25-000002-index.html : 20251017
<SEC-HEADER>0001710496-25-000002.hdr.sgml : 20251017
<ACCEPTANCE-DATETIME>20251017183752
ACCESSION NUMBER:		0001710496-25-000002
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251015
FILED AS OF DATE:		20251017
DATE AS OF CHANGE:		20251017

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Emerson Erik C.
		CENTRAL INDEX KEY:			0001710496
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42545
		FILM NUMBER:		251401943

	MAIL ADDRESS:	
		STREET 1:		2300 WEST SAHARA AVENUE
		STREET 2:		SUITE 800 - #4012
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89102

	FORMER NAME:	
		FORMER CONFORMED NAME:	Emerson Erik
		DATE OF NAME CHANGE:	20170627

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apimeds Pharmaceuticals US, Inc.
		CENTRAL INDEX KEY:			0001894525
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				851099700
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		100 MATAWAN RD
		STREET 2:		SUITE 325
		CITY:			MATAWAN
		STATE:			NJ
		ZIP:			07747
		BUSINESS PHONE:		848-201-5010

	MAIL ADDRESS:	
		STREET 1:		100 MATAWAN RD
		STREET 2:		SUITE 325
		CITY:			MATAWAN
		STATE:			NJ
		ZIP:			07747
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>